These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8678582)

  • 21. Lymphoscintigraphy in cutaneous melanoma: an updated total body atlas of sentinel node mapping.
    Intenzo CM; Truluck CA; Kushen MC; Kim SM; Berger A; Kairys JC
    Radiographics; 2009; 29(4):1125-35. PubMed ID: 19605661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Warthin's tumour, a rare false positive on positron emission tomography in melanoma staging.
    Fogarty GB; Mok MT; Taranto A; Murray WK
    Acta Oncol; 2005; 44(1):87-9. PubMed ID: 15858864
    [No Abstract]   [Full Text] [Related]  

  • 23. [Nuclear medicine study methods using 32P in the preoperative diagnosis of the tumor spread of skin melanoma].
    Savvateeva ZhP; Agranat VZ; Tolkacheva EN
    Radiobiol Radiother (Berl); 1980; 21(2):184-90. PubMed ID: 7465814
    [No Abstract]   [Full Text] [Related]  

  • 24. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 25. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastrointestinal metastasis of malignant melanoma].
    Hackländer T; Schulte KW; Jungblut RM
    Aktuelle Radiol; 1996 May; 6(3):156-8. PubMed ID: 8679741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
    Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
    J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planar coincidence scintigraphy and PET in staging malignant melanoma.
    Steinert HC; Voellmy DR; Trachsel C; Bicik I; Buck A; Huch RA; von Schulthess GK
    J Nucl Med; 1998 Nov; 39(11):1892-7. PubMed ID: 9829578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
    Hafner J
    Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of FDG PET-CT in cutaneous melanoma].
    Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
    Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic mapping aids staging of melanoma.
    Moldofsky PJ
    Diagn Imaging (San Franc); 1998 Jun; 20(6):65-8, 73. PubMed ID: 10180986
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of ultrasound in the assessment of the sentinel node of melanoma patients.
    Voit CA; van Akkooi AC; Eggermont AM
    AJR Am J Roentgenol; 2010 Dec; 195(6):W474-5; author reply W476. PubMed ID: 21098184
    [No Abstract]   [Full Text] [Related]  

  • 34. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
    Bikhchandani J; Wood J; Richards AT; Smith RB
    Head Neck; 2014 Sep; 36(9):1313-6. PubMed ID: 23956077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.
    Mijnhout GS; Hoekstra OS; van Lingen A; van Diest PJ; Adèr HJ; Lammertsma AA; Pijpers R; Meijer S; Teule GJ
    J Clin Pathol; 2003 Apr; 56(4):283-6. PubMed ID: 12663640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic optic neuropathy from cutaneous melanoma detected by positron emission tomographic and computed tomographic scanning.
    Schoenberger SD; Kim SJ; Lavin P
    Arch Ophthalmol; 2012 Sep; 130(9):1223-5. PubMed ID: 22965609
    [No Abstract]   [Full Text] [Related]  

  • 38. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
    Klein M; Freedman N; Lotem M; Marciano R; Moshe S; Gimon Z; Chisin R
    Nuklearmedizin; 2000; 39(3):56-61. PubMed ID: 10834191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of PET.
    Spratt JS
    J Am Coll Surg; 1998 Aug; 187(2):197-8. PubMed ID: 9704968
    [No Abstract]   [Full Text] [Related]  

  • 40. Malignant melanoma and (18)F-FDG-PET: Should the whole body scan include the legs?
    Löffler M; Weckesser M; Franzius Ch; Nashan D; Schober O
    Nuklearmedizin; 2003 Aug; 42(4):167-72. PubMed ID: 12937695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.